Hyperactivation of TLR-IL1R-mediated Akt-mTOR signaling in SIGIRR-deficient tumors leads to cell cycle progression, loss of heterozygosity of APC, and tumor initiation (75). The gene discussed is AKT1; the disease is neoplasm.